Take Care Of YourselfAll the Arguments You Need: to Convince Vaccinated People to Keep Masking, Social Distancing While vaccines significantly reduce the chances of a severe Covid19 infection, no one knows for how long. By Satviki Sanjay
Slow And Steady Wins The RaceCovishield’s Efficacy Rate Is Over 80% With a 12‑Week Gap Between Doses. Why Is India Still Adhering To a Four‑Week Gap? Data shows a four-week period between Covishield doses leads to a 55% efficacy rate. By Devrupa Rakshit
Behind The NumbersWhat Vaccine Efficacy Rates Really Mean An 81% efficacy rate doesn't mean a vaccine only works 81% of the time. By Liesl Goecker
Pick Me Pick MeCovid19 Vaccines Are Now Being Tested on Child Volunteers. But Can Kids Really Volunteer? Given kids' cognitive and emotional immaturity and legal dependency, it's questionable whether they can truly consent to medical research. By Liesl Goecker
Stronger Immune SystemsWhy Reports of Side Effects After a Second Covid Shot Are Not Cause for Concern Fever and general unwellness are signs the vaccine is working and training the immune system to fight the virus. By Liesl Goecker
Good NewsFirst Dose of AstraZeneca’s Vaccine Offers 76% Protection Against Covid Symptoms for 12 Weeks, Suggests Early U.K. Data The analysis suggests that dose alone could curb transmission by two-thirds. By Rajvi Desai
Speed Up The ShotsHow Covid19 Variants Are Making It Even More Critical to Vaccinate Everyone, Quickly Vaccine hesitancy among frontline workers has caused nearly all states to miss their vaccination targets. By Rajvi Desai
Shots Save LivesVaccines Have Saved More Than 37 Million Children’s Lives Over The Past Decade: Report The measles vaccine has been the most life-saving immunization. By Aditi Murti
Ethics ExerciseHow Do We Decide Who Has First Dibs on the Covid Vaccines? The question is uniquely important to India, where the government has agreed to subsidize only the first round of vaccine doses. By Rajvi Desai
Global Health CareUp to Half of India’s Current Covid19 Vaccine Stock Is Reserved for Free Export to Nearby Countries The government has approved the export of both Covishield and Covaxin to 12 nearby countries as a "goodwill gesture." By Devrupa Rakshit
Moral HealthMuslim Clerics Around the World Are Working to Certify Covid19 Vaccines as Halal A rumor that the Chinese vaccine contains pork-derived gelatin has prompted clerics to fast-track halal approval in the name of public health. By Rajvi Desai
Shrouded in SuspicionIndia’s Vaccine Approval, Without Transparency on Clinical Trial Results, Is Eroding Public Trust The current confusion, suspicion at the approval of Bharat Biotech’s vaccine is further evidence of the public's lack of trust in healthcare institutions during the pandemic. By Rajvi Desai
priorities in orderPope Says Getting Covid19 Vaccine Is “Morally Acceptable,” Even if It Contains Fetal Tissue The statement challenges anti-abortion activists who have condemned several Covid19 vaccines that use tissue from aborted fetuses. By Rajvi Desai
Light At The End of the TunnelOxford‑AstraZeneca Pledges to Sell Covid19 Vaccine at Cost to Low‑Income Countries The vaccine's low price, combined with its low-maintenance storage, makes it one of the most accessible for Indians. By Rajvi Desai
Backsliding Into An Epidemic2021 Measles Outbreak Is Likely Due to Vaccine Delays: Experts The Covid19 pandemic and related lockdowns have caused families all over the world to fall behind on children’s vaccine schedules. By Aditi Murti
With a Side of CautionPfizer Says Its Vaccine Is 90% Effective; Here Are the Hurdles That Remain Before It’s Available to the Public There's a lot that must happen before you can get the shots from your doctor. By Rajvi Desai
On The BackfootEffective Covid Vaccine Will Be Meaningless in India Without a Mass Immunization Strategy “We should have started [planning] last month,” said retired bureaucrat and public health expert PV Ramesh. By Kavitha Iyer
Slow And Steady Wins The RaceIndia May Have a Covid19 Vaccine by Early 2021 — But How Effective Will It Be? The first vaccine to market may not provide the longest-lasting immunity, experts warn. By Devrupa Rakshit